Vanguard Group’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$3.11B Buy
12,286,535
+73,014
+0.6% +$18.3M 0.05% 365
2025
Q3
$3.02B Buy
12,213,521
+50,393
+0.4% +$12.1M 0.05% 368
2025
Q2
$2.92B Buy
12,163,128
+205,276
+2% +$47.8M 0.05% 378
2025
Q1
$2.71B Buy
11,957,852
+46,628
+0.4% +$10.3M 0.05% 370
2024
Q4
$2.45B Sell
11,911,224
-137,447
-1% -$30.2M 0.04% 408
2024
Q3
$2.92B Buy
12,048,671
+46,857
+0.4% +$11M 0.05% 361
2024
Q2
$2.63B Buy
12,001,814
+162,162
+1% +$35.2M 0.05% 361
2024
Q1
$2.66B Sell
11,839,652
-24,954
-0.2% -$5.63M 0.05% 364
2023
Q4
$2.61B Buy
11,864,606
+53,526
+0.5% +$11.3M 0.06% 344
2023
Q3
$2.59B Sell
11,811,080
-114,844
-1% -$26M 0.06% 319
2023
Q2
$2.68B Sell
11,925,924
-246
-0% -$49.2K 0.06% 327
2023
Q1
$2.28B Sell
11,926,170
-39,870
-0.3% -$7.71M 0.06% 358
2022
Q4
$2.21B Buy
11,966,040
+123,231
+1% +$21.7M 0.06% 355
2022
Q3
$1.97B Buy
11,842,809
+146,928
+1% +$29.9M 0.06% 364
2022
Q2
$2.41B Buy
11,695,881
+170,112
+1% +$38.4M 0.07% 305
2022
Q1
$2.79B Buy
11,525,769
+143,253
+1% +$33.2M 0.07% 314
2021
Q4
$2.77B Buy
11,382,516
+75,021
+0.7% +$17.1M 0.06% 328
2021
Q3
$2.31B Buy
11,307,495
+579,560
+5% +$124M 0.06% 367
2021
Q2
$2.21B Buy
10,727,935
+1,038,226
+11% +$209M 0.06% 382
2021
Q1
$1.85B Buy
9,689,709
+664,566
+7% +$123M 0.05% 413
2020
Q4
$1.71B Buy
9,025,143
+28,010
+0.3% +$5.23M 0.05% 406
2020
Q3
$1.59B Sell
8,997,133
-513,308
-5% -$82.1M 0.05% 379
2020
Q2
$1.46B Sell
9,510,441
-213,253
-2% -$32.5M 0.05% 386
2020
Q1
$1.36B Buy
9,723,694
+358,408
+4% +$53.6M 0.06% 344
2019
Q4
$1.43B Buy
9,365,286
+1,359,600
+17% +$199M 0.05% 426
2019
Q3
$1.16B Buy
8,005,686
+121,944
+2% +$18.2M 0.04% 468
2019
Q2
$1.17B Buy
7,883,742
+66,013
+0.8% +$8.82M 0.04% 468
2019
Q1
$1B Buy
7,817,729
+115,436
+1% +$13.6M 0.04% 500
2018
Q4
$823M Buy
7,702,293
+186,242
+2% +$20.8M 0.04% 520
2018
Q3
$860M Buy
7,516,051
+133,510
+2% +$15.1M 0.03% 565
2018
Q2
$775M Buy
7,382,541
+169,757
+2% +$17.1M 0.03% 583
2018
Q1
$673M Buy
7,212,784
+104,934
+1% +$9.54M 0.03% 624
2017
Q4
$622M Buy
7,107,850
+117,983
+2% +$10.5M 0.03% 653
2017
Q3
$618M Buy
6,989,867
+110,107
+2% +$9.33M 0.03% 628
2017
Q2
$561M Buy
6,879,760
+107,644
+2% +$8.18M 0.03% 656
2017
Q1
$470M Sell
6,772,116
-321,525
-5% -$22.2M 0.02% 727
2016
Q4
$478M Buy
7,093,641
+190,762
+3% +$12.9M 0.03% 674
2016
Q3
$505M Buy
6,902,879
+172,897
+3% +$12.2M 0.03% 626
2016
Q2
$463M Sell
6,729,982
-46,825
-0.7% -$3.28M 0.03% 638
2016
Q1
$481M Buy
6,776,807
+738,066
+12% +$49.9M 0.03% 610
2015
Q4
$455M Buy
6,038,741
+1,913,706
+46% +$138M 0.03% 623
2015
Q3
$268M Buy
4,125,035
+276,665
+7% +$18.3M 0.02% 825
2015
Q2
$248M Buy
3,848,370
+41,774
+1% +$2.82M 0.02% 922
2015
Q1
$267M Buy
3,806,596
+212,276
+6% +$14M 0.02% 878
2014
Q4
$233M Buy
3,594,320
+81,288
+2% +$5.02M 0.02% 884
2014
Q3
$190M Buy
3,513,032
+44,108
+1% +$2.4M 0.01% 964
2014
Q2
$186M Buy
3,468,924
+45,315
+1% +$2.33M 0.01% 1012
2014
Q1
$163M Buy
3,423,609
+144,118
+4% +$6.75M 0.01% 1040
2013
Q4
$158M Buy
3,279,491
+99,065
+3% +$4.53M 0.01% 1035
2013
Q3
$137M Buy
3,180,426
+210,206
+7% +$9.13M 0.01% 1047
2013
Q2
$127M Buy
+2,970,220
New +$128M 0.01% 1009

Other funds holding STE

Vanguard Group's STE Position: Q4 2025 in Review

Vanguard Group increased its Steris (STE) stake by 0.6% in Q4 2025, buying an estimated $18.3M and bringing the position to 12,286,535 shares worth $3.11B. The position accounts for 0.05% of the portfolio, ranked #365.

Vanguard Group first reported a position in STE in Q2 2013 and has held it in 51 quarters since. 894 funds tracked by Wall St. Rank hold STE as of Q4 2025.

  • Vanguard Group held 12,286,535 shares of Steris worth $3.11B as of Q4 2025.
  • Vanguard Group bought 73,014 Steris shares in Q4 2025, an estimated $18.3M.
  • Steris made up 0.05% of Vanguard Group's portfolio in Q4 2025, its #365 holding.
  • Vanguard Group first reported a position in Steris in Q2 2013 and has held it in 51 quarters since.
  • 894 funds tracked by Wall St. Rank held Steris as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.